Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate the Safety and Clinical Activity of PBCAR20A in Subjects With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) or r/r Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04030195
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:49.157776+00:00
Published At
2023-01-31T00:00:00+00:00
Record Updated At
2023-01-31
Results Posted At
2023-01-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Non-Hodgkin\u0027s Lymphoma, Relapsed", "Chronic Lymphoid Leukemia in Relapse", "Non-Hodgkin\u0027s Lymphoma Refractory", "Chronic Lymphocytic Leukemia", "Lymphoma, Non-Hodgkin", "Leukemia, Lymphocytic, Chronic", "B-cell Chronic Lymphocytic Leukemia", "B-cell Non Hodgkin Lymphoma", "Small Lymphocytic Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-01-31"
protocolSection.identificationModule.nctId
"NCT04030195"
protocolSection.identificationModule.officialTitle
"A Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate the Safety and Clinical Activity of PBCAR20A in Subjects With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) or r/r Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-01-31"

Study condition terms

  • Non-Hodgkin's Lymphoma, Relapsed (protocolSection.conditionsModule.conditions)
  • Chronic Lymphoid Leukemia in Relapse (protocolSection.conditionsModule.conditions)
  • Non-Hodgkin's Lymphoma Refractory (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Lymphoma, Non-Hodgkin (protocolSection.conditionsModule.conditions)
  • Leukemia, Lymphocytic, Chronic (protocolSection.conditionsModule.conditions)
  • B-cell Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • B-cell Non Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Small Lymphocytic Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.